0.000USD0.000åå ŽååŒÂ 07/30, 09:30 (ET)
11.31BæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
Charles River Laboratories International Inc
äž»èŠããŒã¿
238.780å§å€
242.400é«å€
1.05Måºæ¥é«
æå€±é¡çŽè¿12ã¶æPER
18.79äºæ³PER
--çŽè¿12ã¶æé
åœ
2.19%売買å転ç
240.430忥çµå€
234.180å®å€
144.93M売買代é
1098.34æ ªäŸ¡åçç
3.85PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-2.39%ç·è³ç£å©çç
228.88052é±é«å€
1.29åºæ¥é«æ¯ç%
10.30MçŽå©ç
48.17Mæ ªåŒæ°
-3.71801æ ªåœããå©çïŒEPSïŒ
1.46ããŒã¿å€
-6.02%èªå·±è³æ¬å©çç
132.58352é±å®å€
3.42%æ¯ãå¹
30.90%ç²å©çç
11.31BæäŸ¡ç·é¡
2.30ãªã¹ã¯ãªã¿ãŒã³
2.62%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-29 äž»èŠã€ã³ãµã€ã
Charles River Laboratories International Incã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçéåžžã«å¥å
šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸãããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã§ã®é äœã¯384äž20äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯231.44ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžæãã¬ã³ããšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯å¹³åçã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Charles River Laboratories International Incã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Charles River Laboratories International Incã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Charles River Laboratories International Inc ãã¥ãŒã¹
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Charles River Laboratories International Inc
CRL
19
Ionis Pharmaceuticals Inc
IONS
27
ææšî
ææš
売ã(2)
äžç«(2)
è²·ã(3)
ç§»åå¹³å
売ã(0)
äžç«(0)
è²·ã(6)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Charles River Laboratories International Incã®äŒæ¥æ
å ±î
Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
äŒæ¥ã³ãŒãCRL
äŒæ¥åCharles River Laboratories International Inc
æé«çµå¶è²¬ä»»è
ãCEOãFoster (James C)
ãŠã§ããµã€ãhttps://www.criver.com/
æ ªäž»çµ±èšî
ãããã質å
Charles River Laboratories International IncïŒCRLïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îCharles River Laboratories International IncïŒCRLïŒã®çŸåšã®æ ªäŸ¡ã¯234.80ã§ãã
Charles River Laboratories International Incã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îCharles River Laboratories International Incã®ãã£ãã«ãŒã·ã³ãã«ã¯CRLã§ãã
Charles River Laboratories International Incã®52é±é«å€ã¯ãããã§ããïŒ
îCharles River Laboratories International Incã®52é±é«å€ã¯228.88ã§ãã
Charles River Laboratories International Incã®52é±å®å€ã¯ãããã§ããïŒ
îCharles River Laboratories International Incã®52é±å®å€ã¯132.58ã§ãã
Charles River Laboratories International Incã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îCharles River Laboratories International Incã®æäŸ¡ç·é¡ã¯11.31Bã§ãã
Charles River Laboratories International Inc (CRL) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãCharles River Laboratories International IncïŒCRLïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯231.44ã§ãã
Charles River Laboratories International Inc (CRL) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îCharles River Laboratories International IncïŒCRLïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-2.91ã§ãã